About Electromed (NYSEAMERICAN:ELMD)
Electromed, Inc. develops, manufactures and markets airway clearance products, which apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The Company's products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others. As of June 30, 2016, the SmartVest System is available in two models: SV2100 and SQL. The SmartVest System consists of an inflatable therapy garment, a programmable air pulse generator and a single-hose, which delivers air pulses from the generator to the garment. The SmartVest SQL System is small, quiet and light, and offers generator programmability. The Company markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to healthcare providers, particularly those working in intensive care units. The Company sells its products to the home healthcare market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis and neuromuscular disease.
Industry, Sector and Symbol
Industry Advanced Medical Equipment & Technology
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity20.48%
Return on Assets16.89%
Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions
What is Electromed's stock symbol?
Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."
How were Electromed's earnings last quarter?
Electromed, Inc. (NYSEAMERICAN:ELMD) issued its quarterly earnings results on Tuesday, November, 7th. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $6.38 million for the quarter. Electromed had a return on equity of 20.48% and a net margin of 13.01%. View Electromed's Earnings History.
Are investors shorting Electromed?
Electromed saw a drop in short interest in the month of November. As of November 15th, there was short interest totalling 55,554 shares, a drop of 53.0% from the October 31st total of 118,109 shares. Based on an average trading volume of 63,941 shares, the short-interest ratio is currently 0.9 days. Approximately 0.8% of the company's stock are sold short.
Who are some of Electromed's key competitors?
Some companies that are related to Electromed include IRIDEX (IRIX), Edap Tms (EDAP), Fulgent Genetics (FLGT), Neovasc Inc (US) (NVCN), Digirad (DRAD), Biolase (BIOL), Invivo Therapeutics (NVIV), EnteroMedics (RSLS), Dextera Surgical (DXTR), Sphere Medical (SPHR), ArthroCare (ARTC), Cynosure (CYNO), Derma Sciences (DSCI), Hansen Medical (HNSN), Lifeline Scientific (LSIC), Lombard Medical Technologies (LMT), Nanosphere (NSPH) and Solta Medical (SLTM).
Who are Electromed's key executives?
Electromed's management team includes the folowing people:
- Stephen H. Craney, Independent Chairman of the Board (Age 73)
- Kathleen S. Skarvan, President, Chief Executive Officer (Age 61)
- George H. Winn DDS, Vice Chairman, Independent Director (Age 80)
- Jeremy T. Brock CPA, Chief Financial Officer (Age 38)
- William V. Eckles, Independent Director (Age 42)
- Stan K. Erickson, Independent Director (Age 67)
- Lee A. Jones, Independent Director (Age 60)
Who owns Electromed stock?
Electromed's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Tocqueville Asset Management L.P. (3.93%), Algert Global LLC (2.30%), Essex Investment Management Co. LLC (0.91%) and EAM Investors LLC (0.79%). Company insiders that own Electromed stock include Red Oak Partners, Llc, Stan K Erickson, Stephen H Craney and William Eckles. View Institutional Ownership Trends for Electromed.
Who bought Electromed stock? Who is buying Electromed stock?
Electromed's stock was acquired by a variety of institutional investors in the last quarter, including Algert Global LLC, EAM Investors LLC, Essex Investment Management Co. LLC and Tocqueville Asset Management L.P.. Company insiders that have bought Electromed stock in the last two years include Red Oak Partners, Llc, Stan K Erickson, Stephen H Craney and William Eckles. View Insider Buying and Selling for Electromed.
How do I buy Electromed stock?
Shares of Electromed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Electromed's stock price today?
One share of Electromed stock can currently be purchased for approximately $5.75.
How big of a company is Electromed?
Electromed has a market capitalization of $47.50 million.
How can I contact Electromed?
Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.
MarketBeat Community Rating for Electromed (ELMD)MarketBeat's community ratings are surveys of what our community members think about Electromed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Electromed (NYSEAMERICAN:ELMD) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Electromed (NYSEAMERICAN:ELMD) Earnings History and Estimates Chart
Electromed (NYSEAMERICAN ELMD) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/7/2017||Q1 2018||$0.01||$6.38 million||View||N/A|
|9/5/2017||Q4 2017||$0.06||$0.11||$7.27 million||View||Listen|
|5/15/2017||Q3 2017||$0.06||$0.08||$6.67 million||View||N/A|
|2/7/2017||Q217||$0.03||$0.05||$6.21 million||$6.40 million||View||Listen|
|11/8/2016||Q117||$0.03||$0.02||$5.90 million||$5.50 million||View||Listen|
|9/6/2016||Q416||$0.05||$0.04||$6.03 million||$5.69 million||View||N/A|
|5/10/2016||Q3||$0.07||$0.06||$5.70 million||$6.04 million||View||N/A|
|11/10/2015||Q116||$0.04||$4.77 million||$5.00 million||View||N/A|
|9/15/2015||Q415||$0.02||$0.03||$4.67 million||$5.20 million||View||N/A|
|2/10/2015||Q115||$0.05||$4.00 million||$4.90 million||View||N/A|
|11/12/2014||Q1 2015||($0.01)||$0.05||$3.91 million||$4.77 million||View||N/A|
|9/23/2014||Q414||$0.04||$4.00 million||$4.61 million||View||N/A|
|5/13/2014||Q314||($0.12)||$3.80 million||$0.96 million||View||N/A|
|2/11/2014||Q214||($0.03)||($0.03)||$3.54 million||$3.50 million||View||N/A|
|9/25/2013||Q413||($0.05)||($0.05)||$3.55 million||$4.02 million||View||N/A|
|2/13/2013||Q213||($0.05)||$4.80 million||$3.85 million||View||N/A|
Electromed (NYSEAMERICAN:ELMD) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Electromed (NYSEAMERICAN:ELMD)
No dividend announcements for this company have been tracked by MarketBeat.com
Electromed (NYSEAMERICAN ELMD) Insider Trading and Institutional Ownership History
Electromed (NYSEAMERICAN ELMD) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/3/2017||Red Oak Partners, Llc||Major Shareholder||Sell||34,858||$7.50||$261,435.00|| |
|10/2/2017||Red Oak Partners, Llc||Major Shareholder||Sell||4,600||$7.51||$34,546.00|| |
|9/22/2017||Red Oak Partners, Llc||Major Shareholder||Sell||7,455||$7.40||$55,167.00|| |
|9/21/2017||Red Oak Partners, Llc||Major Shareholder||Sell||262,475||$7.52||$1,973,812.00|| |
|9/20/2017||Red Oak Partners, Llc||Major Shareholder||Sell||184,336||$7.53||$1,388,050.08|| |
|3/13/2017||Stephen H Craney||Director||Buy||10,000||$4.64||$46,400.00|| |
|12/5/2016||Stan K Erickson||Director||Buy||1,500||$3.76||$5,640.00|| |
|12/1/2016||Stephen H Craney||Director||Buy||5,000||$3.75||$18,750.00|| |
|11/10/2016||William Eckles||Director||Buy||20,000||$3.61||$72,200.00|| |
|5/17/2016||Red Oak Partners, Llc||Major Shareholder||Buy||8,900||$3.81||$33,909.00|| |
|5/16/2016||Red Oak Partners, Llc||Major Shareholder||Buy||67,531||$3.74||$252,565.94|| |
|5/12/2016||Red Oak Partners, Llc||Major Shareholder||Buy||78,082||$3.84||$299,834.88|| |
|11/16/2015||William Eckles||Director||Buy||60,000||$2.11||$126,600.00|| |
|3/16/2015||Stephen H Craney||Director||Buy||9,900||$2.35||$23,265.00|| |
|12/9/2014||William Eckles||Director||Buy||10,000||$2.46||$24,600.00|| |
|2/25/2013||Stephen H Craney||Director||Buy||50,000||$1.40||$70,000.00|| |
|2/21/2013||Kathleen Skarvan||CEO||Buy||6,050||$1.35||$8,167.50|| |
|2/15/2013||Kathleen Skarvan||CEO||Buy||2,900||$1.35||$3,915.00|| |
|12/14/2012||Kathleen Skarvan||CEO||Buy||8,000||$1.47||$11,760.00|| |
|12/14/2012||Stephen H Craney||Director||Buy||20,000||$1.49||$29,800.00|| |
|12/11/2012||Kathleen Skarvan||CEO||Buy||7,000||$1.41||$9,870.00|| |
|11/15/2012||William Eckles||Director||Buy||9,311||$1.56||$14,525.16|| |
Electromed (NYSEAMERICAN ELMD) News Headlines
Electromed (NYSEAMERICAN:ELMD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Electromed (NYSEAMERICAN:ELMD) Income Statement, Balance Sheet and Cash Flow Statement
Electromed (NYSEAMERICAN ELMD) Stock Chart for Saturday, December, 16, 2017